chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day of 2nd shot: 1) Left arm and left leg tingling/pins and needles 2) Slight arm pain at injection site Day after 2nd shot: 1) Hemorrhage in right eye 2) Eye twitch and floater in left eye 3) Tightness in chest for 2 hours 4) Intense stabbing pain in in right foot where I broke it previously a few years ago (pain lasted only a couple of seconds) 5) Smell aversion 6) "Aura" as if I was going to get an intense headache 7) Hand tingling 8) Heart palpitations 9) Tightness in left ankle On-going since I have the 2nd Pfizer shot: 1) Tingling in left hand (comes and goes) 2) B-12 deficiency (which may explain tingling and heart palpitations, but I did not have this issue before the 2nd vaccine) 3) Tightness in left leg (comes and goes)
Got BEXSERO in left arm on Tuesday 1/24/2017  Neck was a little itchy that night and then Wednesday am woke up and had rash on back of neck, chin, and arms that was itchy.  Did take Benadryl starting last night (1/26/2017) and took at 9pm, 2am, 6am today (1/27/2017) and this has helped some.
01/01/22 presents to ED for "jaundice and pruritus". PMHx of "Heart abnormality (2019), gestational diabetes mellitus, not currently pregnant, and Hypertension"
A 71 y.o. male with a past medical history significant for oxygen dependent COPD, CHF, bronchiectasis, NSCLC, prostate cancer, hypothyroidism, TBI, and seizure disorder who presents to with worsening cough and known Covid infection. Mr. stated that he didn't feel well on 10/31 and was tested for Covid the following day, returning positive. On 11/2, he felt worse with myalgias, fatigue, poor appetite, and weakness. He was started on Dexamethasone for both the Covid infection +/- COPD exacerbation. Unfortunately, his cough has worsened over the last two days. He has appreciated episodes of hemoptysis. No fever, chills, or sweats. He doesn't
Redness at site with swelling and skin was hot to the touch pt also had a fever of 99.8.
Haven't felt well sense; This case was reported by a consumer via interactive digital media and described the occurrence of feeling unwell in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was not recovered/not resolved.   It was unknown if the reporter considered the feeling unwell to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 20-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient got the shingles shot a few years ago from reporting. The patient had not felt well since. Additional Supportive Information: Follow-up would not possible as no contact details were available.
fainted, loss of consciousness for 1-2";fine tremors in fingers, eyes rolled back;placed in supine position for 20";upright sitting 5-10" cool compress to head;
2 minutes after HPV was administered the patient complained of pain in the area seconds later turn blue to color and fainted falling to the left side. Patient did three slight convulsions. Within 10 seconds patient came to and did not remember the event that happened. We kept the patient in the office till mom was comfortable with taking him home
This case was reported by a healthcare professional and described the occurrence of induration in a 30-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). On 22 October 2008 the subject received a dose of FLUARIX at 0.5 ml in the left arm. One day later, on 23 October 2008, a 2 cm by 2 cm area of induration was reported. Additionally, at an unspecified amount of time following administration of FLUARIX, the subject developed arm redness and swelling. The redness was unresolved at the time of reporting and the outcome of induration and swelling were unknown. The subject was treated with warm compresses and was advised to apply warm compresses 4 times daily for the next few days. Follow-up information was received on 12 December 2008, via healthcare professional, who reported the events resolved on an unknown date. The reporting healthcare professional considered the events related to vaccination with FLUARIX.
Shortness of breath, fatigue, body aches, cough, diarrhea, nausea. Supplemental nasal cannula O2, labs, VBG, D-Dimer, chest imaging, COVID-19 test. Low probability of pulmonary embolism; CXR- bilateral hazy opacities on wet read; dexamethasone
On right arm, pt developed a reddened, warm to touch, bruised area 10 x 10 cm. On left arm, pt developed a less reddened, warm to touch 4 x 3.5 cm area. There were no complaints of tenderness or pain. Follow-up showed less warmth and general size or erythema improved.
Client came in and said he experienced tingling and numbness on his face and lips for 8 hours post vaccine injection on 07/27/21 with Pfizer, Lot# EW0175 and on 08/17/21 Pfizer, Lot # EW0168.  He did not take any medication or consult with a doctor afterwards. Today he is here for his Booster vaccine and wants Moderna. After a med consult, he was administered 0.25 ml of Moderna, Lot # 084J21A. The client was advised to wait 30 minutes in observation today. After the 30 minutes, he left without any symptoms or any type of tingling or numbness. He said he felt perfectly fine. We educated the client to look out for any adverse reactions.
Received vaccinations at 10:00 on 01/29/2008, and immediately reported dizziness and exhibited palor. After lying down pulse was 40, resp 8. Following juice administration pallor improved and B/P was 78/40, pulse 42.  By 10:25 B/P was 98/70, pulse was 60.  Patient reported itching on face above eyebrow and lips.  No visible hives were noted.  Benadryl (30mg) administered as appropriate for weight.  By 11:00 B/P was 92/68, pulse 68, itching did not progress, but patient did report continued lethargy, dizziness and inability to stand unassisted.  Patient referred to primary care and transferred in private vehicle by parent.  On 1/29/2008 received a message from child's physician stating episode was probable syncopal episode.
She reports that she received the 2nd dose 10 months after the first dose; No additional AE reported; This spontaneous report has been received from a female patient (reported as "she") of unknown age, reporting on herself. The patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported.  On an unknown date, the patient was prescribed by her physician 3 doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9).  On an unreported date, she received the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, lot #, expiration date, route of administration and anatomical location were not provided) for prophylaxis. It was reported that the second dose was supposed to be administered two months later.  On an unknown date (reported as "10 months after the first"), the patient received the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, lot #, expiration date, route of administration and anatomical location were not provided) (inappropriate schedule of product administration). No additional events were reported.
MUSCLE PAIN THAT STARTED THE DAY AFTER THE SECOND DOSE OF PFIZER COVID VACCINE AND IS PERSISTING AND WORSENING WITH TIME. WE ARE OVER THREE WEEKS OUT AND HIS MUSCLE PAIN SEEMS TO BE SPENDING. THE PAIN STARTED IN THE LEFT SHOULDER AND IS NOW IN BOTH SHOULDERS AND ARMS.
On 9/28/2021 at about 3 AM, I had a migraine-like headache and nasal congestion. At around 8 AM, I had flu-like body aches and fatigue. As time progressed, the fatigue and congestion worsened, and I lost my appetite. I took a home COVID test on 9/30/2021, and the result was positive. On 10/1/2021, I went to a local lab and underwent a rapid test, and again my result was positive. I had a breakthrough case.
Sweats; Hives; Diarrhea; This spontaneous case was reported by a patient family member or friend and describes the occurrence of HYPERHIDROSIS (Sweats), URTICARIA (Hives) and DIARRHOEA (Diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweats), URTICARIA (Hives) and DIARRHOEA (Diarrhea). At the time of the report, HYPERHIDROSIS (Sweats), URTICARIA (Hives) and DIARRHOEA (Diarrhea) had not resolved.            No concomitant medication information was provided. No treatment medication were provided. The symptoms recur up to every 1/7 days.
Today. 6 weeks after 2nd Pfizer dosage,  I experienced extreme dizziness around 9am. The dizziness continued which makes it impossible to lie down to go to sleep. My head has to remain straight up to get some relief.  I have never experienced anything of this sort. Today is the first day and it has persisted.
This spontaneous report as received from a other health professional refers to a 14 years old male patient with asthma and seasonal allergies. The patient was vaccinated with lot # (670048/0963AA) dose 2 GARDASIL, right deltoid on 03-JAN-2012 at 15:54. No other co-suspects were reported. Concomitant medications included: HAVRIX. It was reported that the patient was administered an immunization that was stored at invalid temperatures, the immunization was stored at a temperature of 32 degrees F or less. No adverse reaction occurred. This is one of several reports from the same source. Additional information is not expected.
Pt report left arm pain and weakness after shot -> top of arm then moved to bottom of arm.
burning on the roof of the mouth; Burning of the tongue; soreness in the arm; This case was reported by a consumer via call center representative and described the occurrence of burning mouth in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included glucose oxidase, lactoferrin, lactoperoxidase, lysozyme (Biotene).   In February 2021, the patient received the 1st dose of Shingrix (intramuscular). On 5th February 2021, 3 days after receiving Shingrix, the patient experienced burning mouth and burning tongue. In February 2021, the patient experienced pain in arm. On an unknown date, the outcome of the burning mouth and burning tongue were not recovered/not resolved and the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the burning mouth, burning tongue and pain in arm to be related to Shingrix.  Additional details was reported as follows: The patient reported case for herself. The 1st dose of the Shingrix vaccine received two weeks before day of reporting and experiencing a little soreness in the arm, burning on the roof of the mouth, and burning of the tongue. She stated that the burning developed 3 to 4 days after the shot. She reported that it had got a little better, and had been on and off. She has checked with her dentist for oral thrush, and they confirmed that it was not oral thrush. She stated that nothing else has been changed, and that everything had stayed the same. The patient having to suck on mints and spray on Biotene to ease the burning. She also reported holding water in her mouth also helps. She had a set of bloodwork done that came out fine. The reporter did not consent to follow up.
nurse accidentally administered the Pfizer 12 + dose to the patient who was only 11 years and 10 months.
Full body rash that started on my neck. Went to urgent care on day 2 of rash, today.
This spontaneous report was received from a nurse referring to multiple unspecified patients of unknown age and gender. Pertinent medical histories, drug reactions or allergies and concomitant therapies were not reported. On unspecified dates after 24-MAR-2015, the patients were vaccinated with improperly stored doses of PNEUMOVAX23 (lot # K009105 with an expiry date 21-JAN-2016, doses, frequencies and route were not reported). No adverse effects were reported. It was reported that vaccines were not discontinued. There was no product quality complaint (PQC) involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Patient got sick kind of like the flu; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Patient got sick kind of like the flu) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Patient got sick kind of like the flu). At the time of the report, INFLUENZA LIKE ILLNESS (Patient got sick kind of like the flu) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product were  not provided by the reporter.  Second dose scheduled for 01 Apr 2021.  No treatment information was provided.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. The nurse reported that on 23-JUN-2014 the patient was vaccinated with improperly stored (Oka/Merck) VARIVAX lot# reported as H019447, expiration date: 25-OCT-2014 (route and dose were not reported). No adverse events were reported. This is one of several reports from the same source. Additional information has been requested.
admitted to hospital on 9/26/22 and diagnosed with Guillain-Barre after evaluation by neurologist in the hospital. Starting 9/24/22 patient reported numbness/tingling of feet/hands, weakness with walking and weakness with raising her head above her shoulders. started IVIG on 9/28/22 for 5 days
fever, body aches, sleeping,--24 hours after 2nd vaccine  throwing up and diahria , sore throat- 48 hours after 2nd vaccine
Pt reports malaise, subjective fevers, backache and left arm heaviness, after 1st dose. This occurred 1/2 day, post vax. No serious reaction. Exam normal.
Expired vaccine administered; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant product was provided by the reporter. Reported that no side effects was reported . No treatment medication was provided.
Stated with sore arm n slight aching. 2 days later 100:00 am with vertigo , nausea . Constant. Vertigo with eye movements-not head. Hah same type vertigo with Covid but was sporadic and very short in duration. After second vaccine was constant until yesterday april 1. This am first am without meclizine (have only taken it for 5 days)  with docs order. Still having sporadic short duration episodes but not bad.
The patient received the vaccine on 12/28/2020 around 2:45pm. She reported a headache the next morning which turned into body aches and a cough. She was sent home and advised to call occupation health.
This case was reported by a other health professional via call center representative and described the occurrence of allergic reaction in a 58-year-old female patient who received FLUARIX. The patient's past medical history included rheumatoid arthritis. Previously administered products included FLUARIX with an associated reaction of hypersensitivity (local swelling and induration to 2-3 inches at the site of injection). Concurrent medical conditions included ankylosing spondylitis, allergic reaction to antibiotics and allergy. On an unknown date, the patient received the 2nd dose of FLUARIX (intramuscular) .5 ml. On an unknown date, unknown after receiving FLUARIX, the patient experienced allergic reaction, condition aggravated, extensive swelling of vaccinated limb and injection site swelling. FLUARIX was discontinued. On an unknown date, the outcome of the allergic reaction and condition aggravated were recovered/resolved and the outcome of the extensive swelling of vaccinated limb and injection site swelling were unknown. It was unknown if the reporter considered the allergic reaction, condition aggravated, extensive swelling of vaccinated limb and injection site swelling to be related to FLUARIX. Additional information received: The reporter called to ask if RN in office (the patient) can receive BOOSTRIX and if it has anything in common with FLUARIX TIV. To the best of their knowledge, FLUARIX TIV caused the patient to have an allergic reaction of local swelling and induration to 2-3 inches at site of injection on first dose 2-3 years ago when she was 56-57 yo (see case US2015GSK022607). A repeat dose of FLUARIX TIV the next year resulted in her whole arm swelling, which required doctor's office attention. No details about treatment or lot numbers or exactly where she received all of these injections. After the second reaction she was given skin tests that reacted negative for egg yolk, egg white and gelatin, but immediate reaction of hives at testing site when FLUARIX injection was placed on skin. She was then advised not to ever get an influenza vaccine again, but doctor who performed tests did not pursue further ingredient allergenicity testing. She has three antibiotic allergies according to the reporter this event, but unknown which ones, as well other unknown possible allergies.
This case was reported by a physician via sales rep and described the occurrence of injection site pain in an unspecified number of patients who received BEXSERO for prophylaxis. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, unknown after receiving BEXSERO, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not applicable for this report. The physician was speaking to her general experience and not a specific patient. She said she had experienced a high incidence of injection site pain with BEXSERO.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 28-year-old male patient received BNT162b2 (BNT162B2), on 05Mar2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 28 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was none. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Indication: Treatment of COVID-19; (2022) Negative, notes: an additional positive test after having tested negative a week prior; (2022) Positive, notes: an additional positive test after having tested negative a week prior. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient did not received other medication in 2weeks. The patient received COVID 19 Treatment, Brand  Paxlovid, Treatment start date - 21Jul2022, Treatment stop date - 26Jul2022. The patient other medical history was none. The patient did not had any Known allergies. Rebound of COVID 19 symptoms and an additional positive test after having tested negative a week prior.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201025297 Same patient, different product and event;
Day of Vaccine I had a low grade fever, Injection spot red with little dots, hot to the touch, headache, sleepiness. This went on for 3 days. On Jan. 1, 2021 I started to feel like I was just getting a cold.  Took some cold medicine for 3 days.  But since Jan. 1 all I want to do is SLEEP. I did not get out of bed for 3 days. I now  get up and do what I have to do, but then I have to go take a nap.  I sleep for about 2 to 3 hours then get up and do what I need to then back to bed.  All I want to do is SLEEP!!!  I have gone to see my Doctor and he is telling me that it has to do with the Vaccine. He could not find anything wrong with me.
Patient stated that vaccination caused extreme pain during administration. Shortly afterward she developed a large blister at the injection site with persistent pain interfering with the ability to sleep. Woke up the next morning with pain, swelling, and redness covering a large portion of the upper arm that was warm to the touch. Patient contacted her primary physician who advised her to apply ice and seek medical attention at the immediate care center if swelling continued. At the location patient was advised to mark the area of redness and return if it continued to spread, apply cool compresses several times daily avoiding direct skin contact, ibuprofen 600 mg every 6 hours PRN, BENADRYL 25 mg PO nightly x 3 days; follow up with PCP in 3 days if symptoms have not resolved.
Took shot Friday afternoon and Saturday night Sunday morning started to get rash on my neck and on both arms.; This is a spontaneous report received from a contactable consumer (patient) reported for herself. A 31-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration in left arm on 16Apr2021 at 13:45 (at the age of 32 years old, not pregnant at the time of vaccination) as dose 1, single for covid-19 immunisation. Medical history included rheumatoid arthritis from an unknown date and unknown if ongoing. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other medications the patient received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. The patient took shot on 16Apr2021, friday afternoon and on 17Apr2021 at 01:00 AM saturday night, sunday morning started to get rash on my neck and on both arms. Therapeutic measures were taken as a result of took shot friday afternoon and saturday night sunday morning started to get rash on my neck and on both arms with methyl prednisolone. The event resulted in emergency room/department or urgent care visit. No hospitalization required. Reporter considered events as non-serious. The outcome of event was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.